Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Penicillin g benzathine
Drug ID BADD_D01711
Description Not Available
Indications and Usage For the treatment of several infections include: acute glomerulonephritis, respiratory tract infections, rheumatic fever and chorea, rheumatic heart disease, rheumatic heart disease, syphilis and other venereal diseases.
Marketing Status Prescription; Discontinued
ATC Code J01CE01; J01CE08; S01AA14
DrugBank ID DB09323
KEGG ID D02157
MeSH ID D010401
PubChem ID 656811
TTD Drug ID D0U4YG
NDC Product Code 50090-1666; 60793-701; 60793-702; 50090-1016; 68071-1824; 60793-700
Synonyms Penicillin G Benzathine | Benzathine, Penicillin G | Benzathine Penicillin | Penicillin, Benzathine | Benzathine Benzylpenicillin | Benzylpenicillin, Benzathine | Benzetacil | Bicillin | Bicillin L-A | Bicillin L A | Bicillin LA | Benzathine Benzylpénicilline Panpharma | Brevicilina | Cepacilina | Debecillin | Extencilline | Pendepon | Penduran | Pendysin | Penicillin G Benzathine Anhydrous | Penidural | Peniroger Retard | Permapen | Provipen Benzatina | Tardocillin | Bencelin
Chemical Information
Molecular Formula C48H64N6O12S2
CAS Registry Number 41372-02-5
SMILES CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C.CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC =CC=C3)C(=O)O)C.C1=CC=C(C=C1)CNCCNCC2=CC=CC=C2.O.O.O.O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Ecchymosis24.07.06.002; 23.06.01.001; 01.01.03.001--Not Available
Eosinophilia01.02.04.001--
Euphoric mood19.04.02.006--
Fatigue08.01.01.002--
Feeling abnormal08.01.09.014--Not Available
Feeling hot08.01.09.009--Not Available
Gangrene24.04.05.003; 23.06.06.001; 11.02.01.003--Not Available
Gastrointestinal necrosis24.04.08.006; 07.15.01.003--
Haematochezia07.12.02.003; 24.07.02.012--Not Available
Haematuria24.07.01.047; 20.02.01.006--
Haemoglobin13.01.05.018--Not Available
Haemolytic anaemia01.06.03.002--Not Available
Hallucination, auditory19.10.02.003--Not Available
Hallucination, visual19.10.02.004--Not Available
Hallucinations, mixed19.10.02.007--Not Available
Headache17.14.01.001--
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hypersensitivity10.01.03.003--
Hypersensitivity vasculitis24.05.02.012; 23.06.02.005; 10.02.02.017; 01.01.04.008--Not Available
Hypoaesthesia17.02.06.023--Not Available
Hypotension24.06.03.002--
Hypoxia22.02.02.003--
Injection site reaction12.07.03.015; 08.02.03.014--
Jarisch-Herxheimer reaction10.02.01.002--Not Available
Laryngeal oedema22.04.02.001; 10.01.05.003; 23.04.01.005--
Leukopenia01.02.02.001--Not Available
Livedo reticularis24.03.04.003; 23.06.05.001--Not Available
Loss of consciousness17.02.04.004--Not Available
Lymphadenopathy01.09.01.002--Not Available
Mass08.03.05.003--Not Available
The 2th Page    First    Pre   2 3 4    Next   Last    Total 4 Pages